Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.7.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jul. 31, 2017
Jul. 31, 2016
Cash flows from operating activities:    
Net loss $ (6,900) $ (35,791)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization of property and equipment 1,198 1,567
Amortization of intangible assets 1,214 1,664
Fair value of acquisition-related contingent consideration   249
Stock-based compensation expense 1,530 1,051
Deferred income taxes 79 14,649
Other 8 195
Changes in operating assets and liabilities, excluding impact of acquisition:    
Accounts receivable 4,358 14,023
Unbilled receivables 2,558 (565)
Inventories 57 19
Prepaid expenses and other assets 8 1,053
Accounts payable (2,594) (1,607)
Accrued expenses (3,193) (5,307)
Deferred revenues (870) (5,419)
Other 230 122
Total cash used in operating activities (2,317) (14,097)
Cash flows from investing activities:    
Purchases of property and equipment (274) (403)
Purchases of marketable securities (4,501)  
Proceeds from sale and maturity of marketable securities 4,449 252
Acquisition of business, net of cash acquired   (5,243)
Other investing activities 388 (83)
Total cash provided by (used in) investing activities 62 (5,477)
Cash flows from financing activities:    
Proceeds from issuance of common stock 26 33
Payments of withholding tax on RSU vesting (36) (91)
Other financing activities   (4)
Total cash used in financing activities (10) (62)
Effect of exchange rate changes on cash (742) (431)
Net decrease in cash and cash equivalents (3,007) (20,067)
Cash and cash equivalents, beginning of period 28,302 58,733
Cash and cash equivalents, end of period 25,295 38,666
Supplemental disclosure of cash flow information:    
Income taxes paid $ 183 83
Supplemental disclosure of non-cash investing and financing activities:    
Transfer of items originally classified as inventories to equipment   24
DCC Labs [Member]    
Supplemental disclosure of non-cash investing and financing activities:    
Fair value of common stock issued for acquisition   2,640
Common Stock [Member]    
Supplemental disclosure of non-cash investing and financing activities:    
Fair value of common stock issued for deferred stock consideration obligation   $ 3,454